Pharmacogenomics at the Center of Precision Medicine: Challenges and Perspective in an Era of Big Data

Abstract

Pharmacogenomics (PGx) is one of the core elements of personalized medicine. PGx information reduces the likelihood of adverse drug reactions and optimizes therapeutic efficacy. St Catherine Specialty Hospital in Zagreb/Zabok, Croatia has implemented a personalized patient approach using the RightMed® Comprehensive PGx panel of 25 pharmacogenes plus Facor V Leiden, Factor II and MTHFR genes, which is interpreted by a special counseling team to offer the best quality of care. With the advent of significant technological advances comes another challenge: how can we harness the data to inform clinically actionable measures and how can we use it to develop better predictive risk models? We propose to apply the principles artificial intelligence to develop a medication optimization platform to prevent, manage and treat different diseases.

Cathelicidins and defensins antimicrobial host defense peptides in the treatment of TB and HIV: Pharmacogenomic and nanomedicine approaches towards improved therapeutic outcomes

“…Incorporating pharmacogenomics into practice enables prescribers to follow a personalized medicine approach which can ultimately optimize therapy, reduce adverse effects and drug-drug interactions[ 56 ]. Patients living with HIV and/or TB are one of many patient groups who can benefit from pharmacogenomics implementation.…”

Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities

“…Precision medicine relies on how an individual’s unique molecular profile influences the individual’s susceptibility to disease and response to medical treatment [ 13 ]. Over the past few years, there has been a paradigm shift from a ‘one drug fits all’ traditional approach to a personalized patient orientated approach [ 14 ]. It has been reported that about 95% of an individuals’ drug response is attributed to genetic elements [ 15 ].…”

PharmVIP: A Web-Based Tool for Pharmacogenomic Variant Analysis and Interpretation

“…Although drugs are generally effective and used with low risks of adverse events, response to drugs varies among individuals. Knowledge of variants in genes associated with drug response (pharmacogenes) is vital for optimizing an individual's therapeutic outcome [4]. Pharmacogenes include genes governing pharmacokinetics (PK), i.e., Cytochrome P450 genes, receptor/transporter genes (drug targets) governing pharmacodynamics (PD), and genes with functions related to immune-mediated adverse drug reactions (IM-ADR), i.e., human leukocyte antigen (HLA) genes.…”